imre’s Post

How can health system leaders develop a shared understanding, set goals and continue learning and improvement around racial justice and health equity? Find out as experts discuss in this AMA STEPS Forward® webinar. https://lnkd.in/gpgzHY3M

How can health system leaders develop a shared understanding, set goals and continue learning and improvement around racial justice and health equity? Find out as experts discuss in this AMA STEPS Forward® webinar. https://lnkd.in/gHBdzSyy

In a recent roundtable discussion with Civitas members, we discussed the profound impact of the Political Determinants of Health on health equity. Learn more via our most recent blog post by Jolie Ritzo, MPH: https://lnkd.in/e6WwhaXU #PoliticalDeterminantsofHealth #HealthEquity

AHIP, a URAC strategic partner, has posted a video featuring global health equity expert Dr. LaShawn McIver, who discusses the importance of equity in health care and why tackling disparities in underserved communities should be a priority: https://hubs.la/Q02k8fvS0 #healthcare #healthequity

Dive into the Stanford Think Tank on Diversity & #HealthEquity in Clinical Trials with our on-demand version! Join us in promoting health equity & addressing underrepresentation. #MedEd Two ways to learn: YouTube: Online Module: https://buff.ly/3J0Jwnn

Join us March 7 for a public meeting on the state of NIH research on women’s health. Individuals and organizations can sign up to share their perspectives on research gaps, priorities, health equity, and how NIH research can better meet women’s health needs in the meeting's public comment session: https://ow.ly/qu1650QCTnl #WomensHealth #HealthEquity #HealthResearch

🌐 Diversity, Equity, and Inclusion in Clinical Trials: Overcoming Barriers to Enrollment Excited to share the second installment of our mini blog series on #DEIinClinicalTrials! In this edition, we're shedding light on the common enrollment barriers faced by individuals historically underrepresented in clinical trials. 🔍 Beyond the Norm: Uncovering Hidden Hurdles It's crucial to go beyond the conventional barriers and delve into the systemic issues that limit access. Our industry needs to address not just the obvious challenges but also the deeper-rooted factors that influence participation. 🌟 Spotlight on Systemic Barriers and Interpersonal Hurdles This blog explores how industry-wide systemic barriers and interpersonal challenges can significantly impact someone's ability to join a clinical trial. Let's recognize and work towards dismantling these barriers for a more inclusive future in medical research. 💬 Join the Conversation Your insights and experiences are invaluable. Share your thoughts on how we can collectively overcome these challenges and make clinical trials more accessible to everyone. Together, let's drive positive change! 💪🏽💊 Big thanks to Adela García Chévez and Jonny Holland for your contributions to this blog. #ClinicalTrials #InclusionMatters #HealthEquity #ResearchDiversity #DEI #MedicalResearch #HealthcareInnovation #ClinicalTrialsPatientRecruitment #patientexperience Spectrum Science - a GHMC Company

Our latest in BMC International Journal for Equity in Health with Omkar Nadh Access the article here: https://lnkd.in/gMjxreC3

Health disparity continuum #ISPORAnnual 2024 Happy to meet a wonderful colleague and health equity mentee of Omolola (Lola) Adeoye-Olatunde, PharmD, MS, at #ISPORAnnual 2024. Prajakta Waghmare and Dr Omolola (Lola) Adeoye-Olatunde, PharmD, MS have collaborated to publish a work on disparities in medicare beneficiaries' receiving medication synchronization where it was highlighted that there is a need to expand Med-Sync program enrollment to address health disparities and advance health equity in the United States. See the published study here: https://lnkd.in/gVFS58HJ ISPOR—The Professional Society for Health Economics and Outcomes Research

Prioritizing diversity in clinical trials is more than a goal, it's a crucial step for advancing healthcare equity. Our recent research highlights challenges faced by underrepresented populations and how to address inequalities. Dive into our blog for key insights and our commitment to making a difference.  #ClinicalTrials #HealthEquity #DiversityInResearch #hcmktg https://lnkd.in/gAk2wQ-t